|
J Biol Chem, Vol. 274, Issue 16, 10717-10722, April 16, 1999
Target Cell Susceptibility to Lysis by Human Natural Killer
Cells Is Augmented by (1,3)-Galactosyltransferase and Reduced by
(1,2)-Fucosyltransferase
John H.
Artrip ,
Pawel
Kwiatkowski ,
Robert E.
Michler ,
Shu-Feng
Wang ,
Sorina
Tugulea ,
Jan
Ankersmit ,
Larisa
Chisholm¶,
Ian F. C.
McKenzie¶,
Mauro S.
Sandrin¶, and
Silviu
Itescu
From the College of Physicians and Surgeons, Columbia
University, New York, New York 10032 and ¶ Austin Research
Institute, Heidelberg, Victoria 3084, Australia
Susceptibility of porcine endothelial cells to
human natural killer (NK) cell lysis was found to reflect surface
expression of ligands containing Gal (1,3)GlcNAc, the principal
antigen on porcine endothelium recognized by xenoreactive human
antibodies. Genetically modifying expression of this epitope on porcine
endothelium by transfection with the (1,2)-fucosyltransferase gene
reduced susceptibility to human NK lysis. These results indicate that surface carbohydrate remodeling profoundly affects target cell susceptibility to NK lysis, and suggest that successful transgenic strategies to limit xenograft rejection by NK cells and xenoreactive antibodies will need to incorporate carbohydrate remodeling.
Copyright © 1999 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
M. F. Perdomo, M. Levi, M. Sallberg, and A. Vahlne
From the Cover: Neutralization of HIV-1 by redirection of natural antibodies
PNAS,
August 26, 2008;
105(34):
12515 - 12520.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. C. Baumann, P. Forte, R. J. Hawley, R. Rieben, M. K. J. Schneider, and J. D. Seebach
Lack of Galactose-{alpha}-1,3-Galactose Expression on Porcine Endothelial Cells Prevents Complement-Induced Lysis but Not Direct Xenogeneic NK Cytotoxicity
J. Immunol.,
May 15, 2004;
172(10):
6460 - 6467.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M D Dooldeniya and A N Warrens
Xenotransplantation: where are we today?
J R Soc Med,
March 1, 2003;
96(3):
111 - 117.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Costa, D. F. Barber, and W. L. Fodor
Human NK Cell-Mediated Cytotoxicity Triggered by CD86 and Gal{alpha}1,3-Gal Is Inhibited in Genetically Modified Porcine Cells
J. Immunol.,
April 15, 2002;
168(8):
3808 - 3816.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Miyagawa, H. Murakami, Y. Takahagi, R. Nakai, M. Yamada, A. Murase, S. Koyota, M. Koma, K. Matsunami, D. Fukuta, et al.
Remodeling of the Major Pig Xenoantigen by N-Acetylglucosaminyltransferase III in Transgenic Pig
J. Biol. Chem.,
October 12, 2001;
276(42):
39310 - 39319.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1999 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|